Your browser doesn't support javascript.
loading
BCG vaccination provides protection against IAV but not SARS-CoV-2.
Kaufmann, Eva; Khan, Nargis; Tran, Kim A; Ulndreaj, Antigona; Pernet, Erwan; Fontes, Ghislaine; Lupien, Andréanne; Desmeules, Patrice; McIntosh, Fiona; Abow, Amina; Moorlag, Simone J C F M; Debisarun, Priya; Mossman, Karen; Banerjee, Arinjay; Karo-Atar, Danielle; Sadeghi, Mina; Mubareka, Samira; Vinh, Donald C; King, Irah L; Robbins, Clinton S; Behr, Marcel A; Netea, Mihai G; Joubert, Philippe; Divangahi, Maziar.
Afiliação
  • Kaufmann E; Department of Medicine, Department of Pathology, Department of Microbiology & Immunology, McGill University Health Centre, McGill International TB Centre, Meakins-Christie Laboratories, McGill University, Montreal, QC H4A 3J1, Canada.
  • Khan N; Department of Medicine, Department of Pathology, Department of Microbiology & Immunology, McGill University Health Centre, McGill International TB Centre, Meakins-Christie Laboratories, McGill University, Montreal, QC H4A 3J1, Canada.
  • Tran KA; Department of Medicine, Department of Pathology, Department of Microbiology & Immunology, McGill University Health Centre, McGill International TB Centre, Meakins-Christie Laboratories, McGill University, Montreal, QC H4A 3J1, Canada.
  • Ulndreaj A; Department of Laboratory Medicine and Pathobiology, Department of Immunology, University of Toronto, Toronto General Research Institute, University Health Network, Peter Munk Cardiac Centre, Toronto, ON M5G 2N2, Canada.
  • Pernet E; Department of Medicine, Department of Pathology, Department of Microbiology & Immunology, McGill University Health Centre, McGill International TB Centre, Meakins-Christie Laboratories, McGill University, Montreal, QC H4A 3J1, Canada.
  • Fontes G; Department of Medicine, Department of Pathology, Department of Microbiology & Immunology, McGill University Health Centre, McGill International TB Centre, Meakins-Christie Laboratories, McGill University, Montreal, QC H4A 3J1, Canada.
  • Lupien A; Department of Medicine, Department of Pathology, Department of Microbiology & Immunology, McGill University Health Centre, McGill International TB Centre, Meakins-Christie Laboratories, McGill University, Montreal, QC H4A 3J1, Canada.
  • Desmeules P; Quebec Heart and Lung Institute Research Center, Department of Medical Biochemistry, Molecular Biology and Pathology, Laval University, Quebec City, QC G1V 4G5, Canada.
  • McIntosh F; Department of Medicine, Department of Pathology, Department of Microbiology & Immunology, McGill University Health Centre, McGill International TB Centre, Meakins-Christie Laboratories, McGill University, Montreal, QC H4A 3J1, Canada.
  • Abow A; Department of Laboratory Medicine and Pathobiology, Department of Immunology, University of Toronto, Toronto General Research Institute, University Health Network, Peter Munk Cardiac Centre, Toronto, ON M5G 2N2, Canada.
  • Moorlag SJCFM; Department of Internal Medicine and Radboud Centre of Infectious Diseases (RCI), Radboud University Medical Centre, 6525 GA Nijmegen, Netherlands.
  • Debisarun P; Department of Internal Medicine and Radboud Centre of Infectious Diseases (RCI), Radboud University Medical Centre, 6525 GA Nijmegen, Netherlands.
  • Mossman K; Department of Medicine, Michael G. DeGroote Institute for Infectious Disease Research, McMaster Immunology Research Centre, McMaster University, Hamilton, ON L8N 3Z5, Canada.
  • Banerjee A; Vaccine and Infectious Disease Organization, Department of Veterinary Microbiology, University of Saskatchewan, Saskatoon, SK 7N 5B4, Canada; Department of Biology, University of Waterloo, Waterloo, ON N2L 3G1, Canada.
  • Karo-Atar D; Department of Medicine, Department of Pathology, Department of Microbiology & Immunology, McGill University Health Centre, McGill International TB Centre, Meakins-Christie Laboratories, McGill University, Montreal, QC H4A 3J1, Canada.
  • Sadeghi M; Department of Medicine, Department of Pathology, Department of Microbiology & Immunology, McGill University Health Centre, McGill International TB Centre, Meakins-Christie Laboratories, McGill University, Montreal, QC H4A 3J1, Canada.
  • Mubareka S; Sunnybrook Research Institute, Toronto, ON M4N 3M5, Canada.
  • Vinh DC; Department of Medicine, Department of Pathology, Department of Microbiology & Immunology, McGill University Health Centre, McGill International TB Centre, Meakins-Christie Laboratories, McGill University, Montreal, QC H4A 3J1, Canada.
  • King IL; Department of Medicine, Department of Pathology, Department of Microbiology & Immunology, McGill University Health Centre, McGill International TB Centre, Meakins-Christie Laboratories, McGill University, Montreal, QC H4A 3J1, Canada.
  • Robbins CS; Department of Laboratory Medicine and Pathobiology, Department of Immunology, University of Toronto, Toronto General Research Institute, University Health Network, Peter Munk Cardiac Centre, Toronto, ON M5G 2N2, Canada.
  • Behr MA; Department of Medicine, Department of Pathology, Department of Microbiology & Immunology, McGill University Health Centre, McGill International TB Centre, Meakins-Christie Laboratories, McGill University, Montreal, QC H4A 3J1, Canada.
  • Netea MG; Department of Internal Medicine and Radboud Centre of Infectious Diseases (RCI), Radboud University Medical Centre, 6525 GA Nijmegen, Netherlands; Department for Genomics & Immunoregulation, Life and Medical Sciences Institute (LIMES), University of Bonn, 53115 Bonn, Germany.
  • Joubert P; Quebec Heart and Lung Institute Research Center, Department of Medical Biochemistry, Molecular Biology and Pathology, Laval University, Quebec City, QC G1V 4G5, Canada. Electronic address: philippe.joubert@criucpq.ulaval.ca.
  • Divangahi M; Department of Medicine, Department of Pathology, Department of Microbiology & Immunology, McGill University Health Centre, McGill International TB Centre, Meakins-Christie Laboratories, McGill University, Montreal, QC H4A 3J1, Canada. Electronic address: maziar.divangahi@mcgill.ca.
Cell Rep ; 38(10): 110502, 2022 03 08.
Article em En | MEDLINE | ID: mdl-35235831

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vírus da Influenza A / COVID-19 Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vírus da Influenza A / COVID-19 Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article